2020
Passive anti‐C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series
Sostin N, Ross R, Balbuena‐Merle R, Hendrickson JE, Tormey CA. Passive anti‐C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series. Journal Of Clinical Apheresis 2020, 35: 224-226. PMID: 32110829, DOI: 10.1002/jca.21773.Peer-Reviewed Original ResearchConceptsPlatelet transfusionsRh immune globulin administrationRisk/benefit ratioApheresis platelet transfusionImmune globulin administrationRhIG immunoprophylaxisImmune globulinTransfusion supportAlloantibody formationCase seriesNegative recipientsAlloimmunization riskRhIG administrationReproductive agePassive transferPLT transfusionsTransfusionBlood bankBenefit ratioRhIGApheresis PLTsAdministrationImmunoprophylaxisPatientsSetting
2019
Fatal acute hemolytic transfusion reaction due to anti‐B from a platelet apheresis unit stored in platelet additive solution
Balbuena‐Merle R, West FB, Tormey CA, Hendrickson JE. Fatal acute hemolytic transfusion reaction due to anti‐B from a platelet apheresis unit stored in platelet additive solution. Transfusion 2019, 59: 1911-1915. PMID: 30865314, DOI: 10.1111/trf.15240.Peer-Reviewed Original ResearchConceptsGroup B patientsHemolytic transfusion reactionsDirect antiglobulin testB patientsTransfusion reactionsApheresis unitsBlood group B patientsRelapsed acute myeloid leukemiaAcute hemolytic transfusion reactionAnti-human globulin phaseHigh lactate dehydrogenaseAnti-human globulinAcute myeloid leukemiaRecipient testingDonor testingRecipient variablesExtravascular hemolysisPlatelet transfusionsTransfusion recipientsAntibody screenHigh bilirubinPLT transfusionsAntiglobulin testBlood productsMyeloid leukemiaRed blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease
Balbuena-Merle R, Hendrickson JE. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Transfusion Clinique Et Biologique 2019, 26: 112-115. PMID: 30857806, DOI: 10.1016/j.tracli.2019.02.003.Peer-Reviewed Original ResearchMeSH KeywordsAnemia, HemolyticAnemia, Sickle CellBlood SafetyErythrocytesFranceHumansPractice Guidelines as TopicRiskTime FactorsTransfusion ReactionConceptsHemolytic transfusion reactionsSickle cell diseaseRed blood cell alloimmunizationRBC alloantibodiesTransfusion reactionsRBC alloimmunizationCell diseaseLife-threatening hemolytic transfusion reactionsSubset of patientsBlood bank testingCurrent screening practicesAlternative complement pathwayRBC autoantibodiesTransfusion burdenInflammatory statusPatient populationCase reportRBC exposureBlood donorsScreening practicesHigh prevalenceChronic hemolysisAlloantibodiesBystander hemolysisPatients